The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.41.9.971

The development of imaging technologies for investigating the living human brain has expanded knowledge about schizophrenia and is providing dues about biological factors associated with the disorder. Drawing on these and other developments in the last two decades, the authors review selected structural, functional, neurochemical, immunological, and infectious factors associated with the schizophrenic syndrome. Many of the biological alterations reported have also been found in other psychiatric, neurological, and medical conditions; therefore, the findings have little specificity for schizophrenia and in fact support the heterogeneity of the disorder. Compilation of this review was supported in part by the U.S. Department of Energy under contract DE-Ac02 76H00016, as part of PET studies of schizophrenia. The authors thank Charles L. Bowden, M.D., chief of the division of biological psychiatry at the University of Texas Health Science Center at San Antonio, for his useful suggestions on the manuscript.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.